On repeated use, which of the following inhalational anaesthetic agent can cause hepatitis:
## **Core Concept**
The question tests knowledge of the potential side effects of inhalational anaesthetic agents, specifically their association with hepatitis. Inhalational anaesthetics are widely used in clinical settings for their efficacy in inducing and maintaining anaesthesia. However, some of these agents have been linked to rare but serious side effects, including hepatotoxicity.
## **Why the Correct Answer is Right**
Halothane is a well-known inhalational anaesthetic agent that has been associated with a rare but severe form of hepatitis, known as halothane hepatitis. This condition is believed to result from an immune-mediated response to liver cells that have been altered by the metabolism of halothane. The metabolism of halothane leads to the formation of reactive metabolites that can covalently bind to liver proteins, potentially triggering an immune response. On repeated exposure to halothane, this immune response can lead to liver injury and hepatitis.
## **Why Each Wrong Option is Incorrect**
- **Option A:** Sevoflurane is another inhalational anaesthetic agent. While it does undergo hepatic metabolism and can produce compound A, a nephrotoxin, upon degradation by soda lime, it is not commonly associated with causing hepatitis on repeated use.
- **Option B:** Isoflurane is known for its stability and low metabolism rate. It produces minimal amounts of inorganic fluoride ions and other metabolites, making it less likely to cause organ toxicity, including hepatitis.
- **Option D:** Desflurane is similar to isoflurane in terms of its pharmacokinetic profile and is also known for low metabolism, which reduces the risk of producing toxic metabolites that could cause hepatitis.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that halothane hepatitis is a rare but recognized complication of halothane use, particularly with repeated exposure. The risk factors for developing halothane hepatitis include genetic predisposition, female gender, and obesity. Clinicians must weigh the benefits of using halothane against these risks, especially in patients undergoing procedures where alternative anaesthetics may be suitable.
## **Correct Answer:** . Halothane